Combination of tetrapyridylporphyrins and arene ruthenium(II) complexes to treat synovial sarcoma by photodynamic therapy

Four tetrapyridylporphyrin and four dipyridylporphyrin arene ruthenium complexes have been synthesized and characterized. In these complexes, the porphyrin core is either metal-free or occupied by zinc, and the arene ligand of the arene ruthenium units are either the standard methyl-isopropyl-benzene ([Formula: see text]cymene) or the less common phenylpropanol (PhPrOH) derivative. The porphyrin derivatives are coordinated to four arene ruthenium units or only two, in accordance with the number of pyridyl substituents at the periphery of the porphyrins, 5,10,15,20-tetra(4-pyridyl)-21H,23H-porphine (TPyP) and 5,15-diphenyl-10,20-di(pyridin-4-yl)porphyrin (DPhDPyP). All eight complexes were evaluated as anticancer agents on synovial sarcoma cells, in the presence and absence of light, suggesting that both the arene ligand and the porphyrin core substituent can play a crucial role in fine-tuning the photodynamic activity of such organometallic photosensitizers.

Osmium(ii) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells

Aquation is often acknowledged as a necessary step for metallodrug activity inside the cell. Hemilabile ligands can be used for reversible metallodrug activation. We report a new family of osmium(ii) arene complexes of formula [Os(η6-C6H5(CH2)3OH)(XY)Cl]+/0 (1-13) bearing the hemilabile η6-bound arene 3-phenylpropanol, where XY is a neutral N,N or an anionic N,O- bidentate chelating ligand. Os-Cl bond cleavage in water leads to the formation of the hydroxido/aqua adduct, Os-OH(H). In spite of being considered inert, the hydroxido adduct unexpectedly triggers rapid tether ring formation by attachment of the pendant alcohol-oxygen to the osmium centre, resulting in the alkoxy tethered complex [Os(η6-arene-O-κ1)(XY)] n+. Complexes 1C-13C of formula [Os(η6:κ1-C6H5(CH2)3OH/O)(XY)]+ are fully characterised, including the X-ray structure of cation 3C. Tether-ring formation is reversible and pH dependent. Osmium complexes bearing picolinate N,O-chelates (9-12) catalyse the hydrogenation of pyruvate to lactate. Intracellular lactate production upon co-incubation of complex 11 (XY = 4-Me-picolinate) with formate has been quantified inside MDA-MB-231 and MCF7 breast cancer cells. The tether Os-arene complexes presented here can be exploited for the intracellular conversion of metabolites that are essential in the intricate metabolism of the cancer cell.

Half-sandwich ruthenium(ii) complexes with tethered arene-phosphinite ligands: synthesis, structure and application in catalytic cross dehydrogenative coupling reactions of silanes and alcohols

The preparation of the tethered arene-ruthenium(ii) complexes [RuCl₂{η⁶:κ¹(P)-C₆H₅(CH₂)_nOPR₂}] (R = Ph, n = 1 (9a), 2 (9b), 3 (9c); R = ⁱPr, n = 1 (10a), 2 (10b), 3 (10c)) from the corresponding phosphinite ligands R₂PO(CH₂)_nPh (R = Ph, n = 1 (1a), 2 (1b), 3 (1c); R = ⁱPr, n = 1 (2a), 2 (2b), 3 (2c)) is presented. Thus, in a first step, the treatment at room temperature of tetrahydrofuran solutions of dimers [{RuCl(μ-Cl)(η⁶-arene)}₂] (arene = p-cymene (3), benzene (4)) with 1-2a-c led to the clean formation of the corresponding mononuclear derivatives [RuCl₂(η⁶-p-cymene){R₂PO(CH₂)_nPh}] (5-6a-c) and [RuCl₂(η⁶-benzene){R₂PO(CH₂)_nPh}] (7-8a-c), which were isolated in 66-99% yield. The subsequent heating of 1,2-dichloroethane solutions of these compounds at 120 °C allowed the exchange of the coordinated arene. The substitution process proceeded faster with the benzene derivatives 7-8a-c, from which complexes 9-10a-c were generated in 61-82% yield after 0.5-10 h of heating. The molecular structures of [RuCl₂(η⁶-p-cymene){ⁱPr₂PO(CH₂)₃Ph}] (6c) and [RuCl₂{η⁶:κ¹(P)-C₆H₅(CH₂)_nOPⁱPr₂}] (n = 1 (10a), 2 (10b), 3 (10c)) were unequivocally confirmed by X-ray diffraction methods. In addition, complexes [RuCl₂{η⁶:κ¹(P)-C₆H₅(CH₂)_nOPR₂}] (9-10a-c) proved to be active catalysts for the dehydrogenative coupling of hydrosilanes and alcohols under mild conditions (r.t.). The best results were obtained with [RuCl₂{η⁶:κ¹(P)-C₆H₅(CH₂)₃OPⁱPr₂}] (10c), which reached TOF and TON values up to 117 600 h^-1 and 57 000, respectively.

Hydroxylated phosphines as ligands for chalcogenide clusters: self assembly, transformations and stabilization

This contribution is a documentation of recent advances in the chemistry of chalcogenide polynuclear transition metal complexes coordinated with mono- and di-phosphines functionalized with hydroxo groups. A survey of complexes containing tris(hydroxymethyl)phosphine (THP) is presented. The influence of the alkyl chain in bidentate phosphines, bearing the P–(CH2)x–OH arms, is also analyzed. Finally, isolation and structure elucidation of the complexes with HP(OH)2, P(OH)3, As(OH)3, PhP(OH)2, stabilized by coordination to Ni(0) and Pd(0) centers embedded into chalcogenide clusters, is discussed.

Functionalized arene-ruthenium(II) complexes: dangling vs. tethering side chain

The reactivity of compounds [RuCl2(η(6)-C6H5OCH2CH2OH)(L)] (L = phosphine or phosphite) towards the chloride abstractor AgSbF6 has been investigated. Thus, the treatment of the triphenylphosphite complex [RuCl2(η(6)-C6H5OCH2CH2OH){P(OPh)3}] with one equivalent of AgSbF6 gave rise to the formation of the dinuclear dichloro-bridged species [{Ru(μ-Cl)(η(6)-C6H5OCH2CH2OH){P(OPh)3}}2](2+) as the hexafluoroantimonate salt. On the other hand, the triphenylphosphine analog [RuCl2(η(6)-C6H5OCH2CH2OH)(PPh3)] led, under the same experimental conditions, to the di-ruthenium derivative [{RuCl(η(6)-C6H5OCH2CH2OH)(PPh3)}2(μ-Cl)][SbF6] containing only one Cl-bridge. In sharp contrast, treatment of precursors [RuCl2(η(6)-C6H5CH2CH2CH2OH)(L)] (L = P(OPh)3, PPh3, P(OEt)3) with AgSbF6 resulted in the clean formation of the tethered compounds [RuCl{η(6):κ(1)(O)-C6H5CH2CH2CH2OH}(L)][SbF6]. The differences in reactivity observed have been rationalized by theoretical calculations.

Synthesis of Ruthenium(II) Complexes Containing Hydroxymethylphosphines and Their Catalytic Activities for Hydrogenation of Supercritical Carbon Dioxide

Ligand substitution of RuCl2[P(C6H5)3]3 and Cp*RuCl(isoprene) (Cp*=1,2,3,4,5-pentamethylcyclopentadienyl) complexes with hydroxymethylphosphines was investigated to develop new catalyst systems for CO2 hydrogenation. A reaction of P(C6H5)2CH2OH with RuCl2[P(C6H5)3]3 in CH2Cl2 gave Ru(H)Cl(CO)[P(C6H5)2CH2OH]3 (1), which was characterized by NMR spectroscopy and X-ray crystallographic analysis. An isotope labeling experiment using P(C6H5)213CH2OH indicated that the carbonyl moiety in complex 1 originated from formaldehyde formed by degradation of the hydroxymethylphosphine. Elimination of formaldehyde from PCy2CH2OH (Cy=cyclohexyl) was also promoted by treatment of RuCl2[P(C6H5)3]3 in ethanol to give RuCl2(PHCy2)4 under mild conditions. On the other hand, the substitution reaction using Cp*RuCl(isoprene) with the hydroxymethylphosphine ligands proceeded smoothly with formation of Cp*RuCl(L)2 [2a-2c; L=P(C6H5)2CH2OH, PCy(CH2OH)2, and P(CH2OH)3] in good yields. The isolable hydroxymethylphosphine complexes 1 and 2 efficiently catalyzed the hydrogenative amidation of supercritical carbon dioxide (scCO2) to N,N-dimethylformamide (DMF).